Riskpilot← Back to searchSign inGet full accessFinesse Healthtech AB
ABActiveOrg 5564836673Erik Dahlbergsgatan 4Wholesale of information and communication equipment · NACE 4650Est. 19940 employees
Revenue 2025
SEK 7,5M
+119% vs 2024
EBITDA margin
9.1%
-2% vs 2024
Equity ratio
25.0%
Financial strength
Net profit 2025
SEK 341K
-2% vs 2024
| Revenue | SEK 7,5M | +119% |
| EBITDA | SEK 689K | -2% |
| Net profit | SEK 341K | -2% |
| Total assets | SEK 2M | +35% |
| Equity | SEK 499K | -11% |
| Employees | 0 | — |
Legal name
Finesse Healthtech AB
Org number
5564836673
Legal form
Aktiebolag
NACE code
4650 · Wholesale of information and communication equipment
Founded
2 mars 1994
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet inom marknadsföring, företagsutveckling, import och export, e-handel, personlig utveckling och hälsa, utbildningsverksamhet, fotografering och influencer marketing samt därmed förenlig verksamhet. Bolaget ska också vara verksamma inom området fastighetsförvaltning.
Address
Erik Dahlbergsgatan 4
Phone
+4631899630
Email
edvin@finessesverige.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 213 | 1 630 | 2 379 | 3 436 | 7 541 |
| Staff expenses | — | — | — | −598 | −514 |
| EBITDA | 177 | 2 | 156 | 705 | 689 |
| Depreciation & amort. | −0 | −0 | −0 | −106 | −112 |
| EBIT | 177 | 2 | 156 | 600 | 577 |
| Net financials | 1 | 17 | −4 | −1 | −5 |
| Profit before tax | 133 | 19 | 116 | 449 | 430 |
| Tax | −16 | −4 | −20 | −101 | −88 |
| Net profit | 117 | 15 | 96 | 349 | 341 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 312 | 371 | 950 | 1 480 | 1 994 |
| Equity | 168 | 116 | 212 | 558 | 499 |
| Long-term debt | 0 | 0 | 0 | 214 | 104 |
| Short-term debt | 100 | 211 | 655 | 476 | 1 016 |
| Total debt | 100 | 211 | 655 | 690 | 1 119 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20212025
Equity ratio
25.0%
This company
38.2%
Market median
-35% vs market
20212025
Return on equity
68.4%
This company
18.4%
Market median
+272% vs market
20212025
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20212025
Asset turnover
3.78×
This company
1.12×
Market median
+237% vs market
20212025
Debt / equity
3.00×
This company
0.62×
Market median
-384% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Finesse Healthtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Henry Ruben Munkevik | Deputy Board Member | 0 companies |
| Sara Thi Le | Board of Directors | 0 companies |
| Karl Edvin Amadeus Berggren | Deputy Board Member | 0 companies |
| Helen Elisabeth Munkevik Kenzler | Board of Directors | 0 companies |